| D20 | HIV service delivery to key populations in the time of COVID-19: experiences from India | Oral abstract session with live Q&A | Adaptations of HIV treatment services during COVID-19 |
| D2 | VIBRA trial ' Village-based refill of ART following home-based same-day ART initiation: a cluster-randomized clinical trial | Oral abstract session with live Q&A | Impact evaluation of differentiated service delivery |
| D2 | The Community HIV Epidemic Control Model: a community-based intervention to achieve 90-90-90 via comprehensive HIV differentiated service delivery in rural communities in Zambia | Oral abstract session with live Q&A | Impact evaluation of differentiated service delivery |
| D12 | Using multi-disease health screening campaigns to increase uptake of health and HIV testing services (HTS) in the Democratic Republic of the Congo (DRC) | Oral abstract session with live Q&A | Uptake of HIV testing |
| D108 | Combined interventions to accelerate delivery on outcomes for young children affected by HIV in southern Africa | Oral abstract session with live Q&A | Safe housing, social protection and other care and support for people affected by HIV |
| D107 | Reduction trends in AIDS indicators (incidence, hospitalization and mortality rates) associated with conditional cash transfer measures in Brazil: an ecological study | Oral abstract session with live Q&A | Financial incentives, micro-finance, and other economic approaches |
| A12 | Comparative functional analysis of HIV-1 accessory proteins Nef and Vpu in African LTNPs and chronic progressors | Oral abstract session with live Q&A | Correlates of HIV susceptibility and disease progression (biomarkers and genetics) |
| B33 | Efficacy and safety of long-acting subcutaneous lenacapavir in phase 2/3 in heavily treatment-experienced people with HIV: week 26 results (Capella study) | Oral abstract session with live Q&A | ART in highly treatment-experienced people |
| C16 | Initial results of recent HIV infection surveillance in Cambodia, 2020 | Oral abstract session with live Q&A | Novel methods/algorithms for detecting acute and recent HIV infections |
| D20 | Impact of COVID-19 on HIV treatment interruption in seven PEPFAR countries, April'June 2020 | Oral abstract session with live Q&A | Adaptations of HIV treatment services during COVID-19 |